Skip to main content
Top
Published in: European Child & Adolescent Psychiatry 5/2017

Open Access 01-05-2017 | Original Contribution

Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder

Authors: Maria Emilsson, Per A. Gustafsson, Gisela Öhnström, Ina Marteinsdottir

Published in: European Child & Adolescent Psychiatry | Issue 5/2017

Login to get access

Abstract

Adherence to attention deficit hyperactivity disorder (ADHD) treatment is important because, when untreated, it may have serious consequences with lifelong effects. In the case of adolescents on long-term medicine prescription, more knowledge is needed regarding adherence and factors influencing adherence, which was the purpose of this study. Adolescents (n = 101) on ADHD medication ≥6 months were administrated questionnaires at a monitoring appointment: Medication Adherence Report Scale (MARS), beliefs about medicines (BMQ) and the Brief Illness Perception Questionnaire (B-IPQ). Adherence was high, the mean value was 88% of the maximum MARS score, and correlated positively with the “BMQ-necessity-concerns differential” but negatively with “BMQ-concerns” and “BMQ-side effects”. Adolescents with more belief in the necessity of the medication, less concerns and less experience of side effects tended to be more adherent to medication prescription (“intentional non-adherence”), while “unintentional non-adherence” (forgetfulness) was associated with how much they perceived that their ADHD affected their lives. In a multiple regression model, the variance of MARS total (R 2 = 0.21) and “intentional non-adherence” (R 2 = 0.24) was explained by the “BMQ-necessity–concern differential” and “BMQ-experienced side effects”. The variance of “unintentional non-adherence” (R 2 = 0.12) was explained by the “BMQ-necessity–concern differential” and “B-IPQ-consequences of ADHD”. In conclusion, adolescents on long-term medication reported good adherence, mainly influenced by more beliefs in the necessity versus concerns of the medications, less experienced side effects and more perceived consequences of ADHD. BMQ could be useful to identify risks of low adherence, which should be counteracted by partially gender-specific interventions.
Appendix
Available only for authorised users
Literature
2.
go back to reference Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, Lepine JP, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409. doi:10.1192/bjp.bp.106.034389 CrossRefPubMed Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, Lepine JP, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409. doi:10.​1192/​bjp.​bp.​106.​034389 CrossRefPubMed
4.
go back to reference NICE (2013) Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. The British Psychological Society & The Royal College of Psychiatrists, Leicester NICE (2013) Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. The British Psychological Society & The Royal College of Psychiatrists, Leicester
5.
go back to reference Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27(5):699–711. doi:10.1016/s0893-133x(02)00346-9 CrossRefPubMed Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27(5):699–711. doi:10.​1016/​s0893-133x(02)00346-9 CrossRefPubMed
7.
go back to reference Turgay A, Goodman DW, Asherson P, Lasser RA, Babcock TF, Pucci ML, Barkley R (2012) Lifespan persistence of ADHD: the life transition model and its application. J Clin Psychiatry 73(2):192–201. doi:10.4088/JCP.10m06628 CrossRefPubMed Turgay A, Goodman DW, Asherson P, Lasser RA, Babcock TF, Pucci ML, Barkley R (2012) Lifespan persistence of ADHD: the life transition model and its application. J Clin Psychiatry 73(2):192–201. doi:10.​4088/​JCP.​10m06628 CrossRefPubMed
9.
go back to reference Chang Z, Lichtenstein P, Halldner L, D’Onofrio B, Serlachius E, Fazel S, Langstrom N, Larsson H (2014) Stimulant ADHD medication and risk for substance abuse. J Child Psychol Psychiatry 55(8):878–885. doi:10.1111/jcpp.12164 CrossRefPubMed Chang Z, Lichtenstein P, Halldner L, D’Onofrio B, Serlachius E, Fazel S, Langstrom N, Larsson H (2014) Stimulant ADHD medication and risk for substance abuse. J Child Psychol Psychiatry 55(8):878–885. doi:10.​1111/​jcpp.​12164 CrossRefPubMed
12.
go back to reference Sabaté E (ed) (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva Sabaté E (ed) (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva
17.
go back to reference Gau SS, Shen HY, Chou MC, Tang CS, Chiu YN, Gau CS (2006) Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol 16(3):286–297. doi:10.1089/cap.2006.16.286 CrossRefPubMed Gau SS, Shen HY, Chou MC, Tang CS, Chiu YN, Gau CS (2006) Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol 16(3):286–297. doi:10.​1089/​cap.​2006.​16.​286 CrossRefPubMed
18.
go back to reference Ferrin M, Taylor E (2011) Child and caregiver issues in the treatment of attention deficit-hyperactivity disorder: education, adherence and treatment choice. Future Neurol 6(3):399–413. doi:10.2217/fnl.11.5 CrossRef Ferrin M, Taylor E (2011) Child and caregiver issues in the treatment of attention deficit-hyperactivity disorder: education, adherence and treatment choice. Future Neurol 6(3):399–413. doi:10.​2217/​fnl.​11.​5 CrossRef
19.
go back to reference Hodgkins P, Sasane R, Christensen L, Harley C, Liu F (2011) Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population. Curr Med Res Opin 27(Suppl 2):53–62. doi:10.1185/03007995.2011.623158 CrossRefPubMed Hodgkins P, Sasane R, Christensen L, Harley C, Liu F (2011) Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population. Curr Med Res Opin 27(Suppl 2):53–62. doi:10.​1185/​03007995.​2011.​623158 CrossRefPubMed
21.
go back to reference Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, Hechtman L, Chuang S, Wells KC, Pelham W, Cooper T, Elliott G, Newcorn JH (2009) Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry 48(5):501–510. doi:10.1097/CHI.0b013e31819c23ed CrossRefPubMed Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, Hechtman L, Chuang S, Wells KC, Pelham W, Cooper T, Elliott G, Newcorn JH (2009) Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry 48(5):501–510. doi:10.​1097/​CHI.​0b013e31819c23ed​ CrossRefPubMed
23.
go back to reference Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, Haro JM (2013) Predictors and consequences of adherence to treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia. Patient Prefer Adherence 7:987995. doi:10.2147/PPA.S50628 Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, Haro JM (2013) Predictors and consequences of adherence to treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia. Patient Prefer Adherence 7:987995. doi:10.​2147/​PPA.​S50628
25.
go back to reference Wehmeier PM, Dittmann RW, Banaschewski T (2014) Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: results from the COMPLY observational study. Atten Deficit Hyperact Disord 7:165–174. doi:10.1007/s12402-014-0156-8 CrossRef Wehmeier PM, Dittmann RW, Banaschewski T (2014) Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: results from the COMPLY observational study. Atten Deficit Hyperact Disord 7:165–174. doi:10.​1007/​s12402-014-0156-8 CrossRef
27.
go back to reference Storebø OJ, Krogh HB, Ramstad E, Moreira-Maia CR, Holmskov M, Skoog M, Nilausen TD, Magnusson FL, Zwi M, Gillies D, Rosendal S, Groth C, Rasmussen KB, Gauci D, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C (2015) Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. BMJ 351:h5203. doi:10.1136/bmj.h5203 CrossRefPubMedPubMedCentral Storebø OJ, Krogh HB, Ramstad E, Moreira-Maia CR, Holmskov M, Skoog M, Nilausen TD, Magnusson FL, Zwi M, Gillies D, Rosendal S, Groth C, Rasmussen KB, Gauci D, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C (2015) Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. BMJ 351:h5203. doi:10.​1136/​bmj.​h5203 CrossRefPubMedPubMedCentral
28.
go back to reference Faraone SV (2009) Using meta-analysis to compare the efficacy of medications for attention-deficit/hyperactivity disorder in youths. P T 34(12):678–694PubMedPubMedCentral Faraone SV (2009) Using meta-analysis to compare the efficacy of medications for attention-deficit/hyperactivity disorder in youths. P T 34(12):678–694PubMedPubMedCentral
30.
go back to reference Charach A, Skyba A, Cook L, Antle BJ (2006) Using stimulant medication for children with ADHD: what do parents say? A brief report. J Can Acad Child Adolesc Psychiatry 15(2):75–83PubMedPubMedCentral Charach A, Skyba A, Cook L, Antle BJ (2006) Using stimulant medication for children with ADHD: what do parents say? A brief report. J Can Acad Child Adolesc Psychiatry 15(2):75–83PubMedPubMedCentral
31.
go back to reference Ferrin M, Ruiz-Veguilla M, Blanc-Betes M, Abd SE, Lax-Pericall T, Sinclair M, Taylor E (2012) Evaluation of attitudes towards treatment in adolescents with attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 21(7):387–401. doi:10.1007/s00787-012-0277-6 CrossRefPubMed Ferrin M, Ruiz-Veguilla M, Blanc-Betes M, Abd SE, Lax-Pericall T, Sinclair M, Taylor E (2012) Evaluation of attitudes towards treatment in adolescents with attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 21(7):387–401. doi:10.​1007/​s00787-012-0277-6 CrossRefPubMed
34.
go back to reference Knipp DK (2006) Teens’ perceptions about attention deficit/hyperactivity disorder and medications. J Sch Nurs 22(2):120–125CrossRefPubMed Knipp DK (2006) Teens’ perceptions about attention deficit/hyperactivity disorder and medications. J Sch Nurs 22(2):120–125CrossRefPubMed
35.
go back to reference Horne R, Weinman J (1999) Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47(6):555–567CrossRefPubMed Horne R, Weinman J (1999) Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47(6):555–567CrossRefPubMed
36.
go back to reference Horne R, Weinman J, Hankins M (1999) The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 14(1):1–24CrossRef Horne R, Weinman J, Hankins M (1999) The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 14(1):1–24CrossRef
38.
go back to reference Horne R (2003) Treatment perceptions and self-regulation. In: Cameron LD, Leventhal H (eds) The self-regulation of health and illness behaviour. Routledge, New York, pp 138–153 Horne R (2003) Treatment perceptions and self-regulation. In: Cameron LD, Leventhal H (eds) The self-regulation of health and illness behaviour. Routledge, New York, pp 138–153
39.
go back to reference Chapman SC, Barnes N, Barnes M, Wilkinson A, Hartley J, Piddock C, Weinman J, Horne R (2015) Changing adherence-related beliefs about ICS maintenance treatment for asthma: feasibility study of an intervention delivered by asthma nurse specialists. BMJ Open 5(6):e007354. doi:10.1136/bmjopen-2014-007354 CrossRefPubMedPubMedCentral Chapman SC, Barnes N, Barnes M, Wilkinson A, Hartley J, Piddock C, Weinman J, Horne R (2015) Changing adherence-related beliefs about ICS maintenance treatment for asthma: feasibility study of an intervention delivered by asthma nurse specialists. BMJ Open 5(6):e007354. doi:10.​1136/​bmjopen-2014-007354 CrossRefPubMedPubMedCentral
40.
go back to reference Leventhal H, Diefenbach M, Leventhal EA (1992) Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res 16(2):143–163CrossRef Leventhal H, Diefenbach M, Leventhal EA (1992) Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res 16(2):143–163CrossRef
41.
go back to reference Broadbent E, Petrie KJ, Main J, Weinman J (2006) The brief illness perception questionnaire. J Psychosom Res 60(6):631–637CrossRefPubMed Broadbent E, Petrie KJ, Main J, Weinman J (2006) The brief illness perception questionnaire. J Psychosom Res 60(6):631–637CrossRefPubMed
43.
go back to reference Horne R, Clatworthy J (2010) Adherence to advance and treatment. In: French D, Vedhara K, Kaptein AA, Weinman J (eds) Health psychology, 2nd edn. Wiley-Blackwell, Chichester, pp 175–188 Horne R, Clatworthy J (2010) Adherence to advance and treatment. In: French D, Vedhara K, Kaptein AA, Weinman J (eds) Health psychology, 2nd edn. Wiley-Blackwell, Chichester, pp 175–188
46.
go back to reference Horne R, Hankins M (2004) The Medication Adherence Report Scale (MARS). University of Brighton, Brighton Horne R, Hankins M (2004) The Medication Adherence Report Scale (MARS). University of Brighton, Brighton
47.
go back to reference Bowskill R, Clatworthy J, Parham R, Rank T, Horne R (2007) Patients’ perceptions of information received about medication prescribed for bipolar disorder: implications for informed choice. J Affect Disord 100(1–3):253–257CrossRefPubMed Bowskill R, Clatworthy J, Parham R, Rank T, Horne R (2007) Patients’ perceptions of information received about medication prescribed for bipolar disorder: implications for informed choice. J Affect Disord 100(1–3):253–257CrossRefPubMed
49.
go back to reference Mårdby AC, Åkerlind I, Jörgensen T (2007) Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns 69(1–3):158–164CrossRefPubMed Mårdby AC, Åkerlind I, Jörgensen T (2007) Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns 69(1–3):158–164CrossRefPubMed
50.
go back to reference George J, Kong DC, Thoman R, Stewart K (2005) Factors associated with medication nonadherence in patients with COPD. Chest 128(5):3198–3204CrossRefPubMed George J, Kong DC, Thoman R, Stewart K (2005) Factors associated with medication nonadherence in patients with COPD. Chest 128(5):3198–3204CrossRefPubMed
52.
go back to reference Altman DG (1991) Practical statistics for medical research. Statistics texts. Chapman and Hall, London Altman DG (1991) Practical statistics for medical research. Statistics texts. Chapman and Hall, London
53.
go back to reference Pallant J (2007) SPSS survival manual: a step-by-step guide to data analysis using SPSS version 15. McGraw-Hill Education, Maidenhead Pallant J (2007) SPSS survival manual: a step-by-step guide to data analysis using SPSS version 15. McGraw-Hill Education, Maidenhead
54.
go back to reference Gau SS, Chen SJ, Chou WJ, Cheng H, Tang CS, Chang HL, Tzang RF, Wu YY, Huang YF, Chou MC, Liang HY, Hsu YC, Lu HH, Huang YS (2008) National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J Clin Psychiatry 69(1):131–140CrossRefPubMed Gau SS, Chen SJ, Chou WJ, Cheng H, Tang CS, Chang HL, Tzang RF, Wu YY, Huang YF, Chou MC, Liang HY, Hsu YC, Lu HH, Huang YS (2008) National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J Clin Psychiatry 69(1):131–140CrossRefPubMed
56.
go back to reference Charach A, Dashti B, Carson P, Booker L, Lim CG, Lillie E, Yeung E, Manu J, Raina P, Schachar R (2011) Attention deficit hyperactivity disorder: effectiveness of treatment in at-risk preschoolers; long-term effectiveness in all ages; and variability in prevalence, diagnosis, and treatment. Agency for Healthcare Research and Quality (US), Rockville Charach A, Dashti B, Carson P, Booker L, Lim CG, Lillie E, Yeung E, Manu J, Raina P, Schachar R (2011) Attention deficit hyperactivity disorder: effectiveness of treatment in at-risk preschoolers; long-term effectiveness in all ages; and variability in prevalence, diagnosis, and treatment. Agency for Healthcare Research and Quality (US), Rockville
59.
go back to reference Emilsson M, Berndtsson I, Lötvall J, Millqvist E, Lundgren J, Johansson Å, Brink E (2011) The influence of personality traits and beliefs about medicines on adherence to asthma treatment. Primary Care Respir J 20(2):141–147. doi:10.4104/pcrj.2011.00005 CrossRef Emilsson M, Berndtsson I, Lötvall J, Millqvist E, Lundgren J, Johansson Å, Brink E (2011) The influence of personality traits and beliefs about medicines on adherence to asthma treatment. Primary Care Respir J 20(2):141–147. doi:10.​4104/​pcrj.​2011.​00005 CrossRef
60.
go back to reference Conner DF (2006) Stimulants. In: Barkley RA (ed) Attention-deficit hyperactivity disorder, 3rd edn. Guilford Press, New York, pp 608–647 Conner DF (2006) Stimulants. In: Barkley RA (ed) Attention-deficit hyperactivity disorder, 3rd edn. Guilford Press, New York, pp 608–647
61.
go back to reference Spencer T (2006) Antidepressant and specific norepinephrine reuptake inhibitor treatments. In: Barkley RA (ed) Attention-deficit hyperactivity disorder, 3rd edn. Guilford Press, New York, pp 647–657 Spencer T (2006) Antidepressant and specific norepinephrine reuptake inhibitor treatments. In: Barkley RA (ed) Attention-deficit hyperactivity disorder, 3rd edn. Guilford Press, New York, pp 647–657
62.
go back to reference Storebo OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbol B, Simonsen E, Gluud C (2015) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev 11:CD009885. doi:10.1002/14651858.CD009885.pub2 Storebo OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbol B, Simonsen E, Gluud C (2015) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev 11:CD009885. doi:10.​1002/​14651858.​CD009885.​pub2
64.
go back to reference Cooper V, Metcalf L, Versnel J, Upton J, Walker S, Horne R (2015) Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study. NPJ Prim Care Respir Med 25:15026. doi:10.1038/npjpcrm.2015.26 CrossRefPubMedPubMedCentral Cooper V, Metcalf L, Versnel J, Upton J, Walker S, Horne R (2015) Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study. NPJ Prim Care Respir Med 25:15026. doi:10.​1038/​npjpcrm.​2015.​26 CrossRefPubMedPubMedCentral
66.
go back to reference Joseph A, Davis KL, Fridman M, Gustafsson PA, Quintero J, Sikirica V, Banaschewski T (2016) Characteristics and treatment patterns of children and adolescents with attention-deficit/hyperactivity disorder in real-world practice settings. Paper presented at the European Congress of Psychiatry, Madrid, Spain Joseph A, Davis KL, Fridman M, Gustafsson PA, Quintero J, Sikirica V, Banaschewski T (2016) Characteristics and treatment patterns of children and adolescents with attention-deficit/hyperactivity disorder in real-world practice settings. Paper presented at the European Congress of Psychiatry, Madrid, Spain
67.
go back to reference Newcorn JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ, Michelson D (2008) Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry 165(6):721–730. doi:10.1176/appi.ajp.2007.05091676 CrossRefPubMed Newcorn JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ, Michelson D (2008) Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry 165(6):721–730. doi:10.​1176/​appi.​ajp.​2007.​05091676 CrossRefPubMed
68.
69.
71.
go back to reference Connelly LM (2011) Research roundtable. Cronbach’s alpha. Medsurg Nurs 20(1):44–45 Connelly LM (2011) Research roundtable. Cronbach’s alpha. Medsurg Nurs 20(1):44–45
Metadata
Title
Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder
Authors
Maria Emilsson
Per A. Gustafsson
Gisela Öhnström
Ina Marteinsdottir
Publication date
01-05-2017
Publisher
Springer Berlin Heidelberg
Published in
European Child & Adolescent Psychiatry / Issue 5/2017
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-016-0919-1

Other articles of this Issue 5/2017

European Child & Adolescent Psychiatry 5/2017 Go to the issue